 The Food and Drug Administration on Monday authorized a test developed by Laboratory Corporation of America Holdings LH, -0.85 that allows people in the U.S. to self-test for respiratory syncytial virus RSV, a type of common cold, as well as the flu and COVID-19. The test does not require a prescription. 